One year follow-up of the multi-centre European PARTNER transcatheter heart valve study
T. Lefèvre(Institut Cardiovasculaire Paris Sud), A. Pieter Kappetein(Erasmus University Rotterdam), Matthias Thielmann, Martin Thomas(Marqués de Valdecilla University Hospital), Dominique Himbert(Hôpital Bichat-Claude-Bernard), Patrick Nataf(Hôpital Bichat-Claude-Bernard), Patrick W. Serruys(Erasmus MC), Gerhard Wimmer‐Greinecker(Klinik Lüneburger Heide), Ernst Wolner(Medical University of Vienna), Volker Schächinger(Klinikum Fulda), Bernard De Bruyne(Onze Lieve Vrouwziekenhuis Hospital), Mauro Romano, Hélène Eltchaninoff(Inserm)
Cited by 377
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
|New England Journal of Medicine|2013|1.5k